Monograph Title | Section | Source Publication | Page Number | Errata Post Date | Errata Official Date | Target Errata Print Publication Sort ascending | Target Online Fix Publication | Description |
---|---|---|---|---|---|---|---|---|
IRINOTECAN HYDROCHLORIDE INJECTION | DEFINITION | USPNF Online | Online | 26-Aug-2022 | 1-Sep-2022 | NA | NA | Change NTL 90.0% and NMT 110.0% to: NLT 90.0% and NMT 110.0% |
ISOBUTYL ALCOHOL | ASSAY/Procedure | USPNF Online | Online | 27-Jan-2023 | 1-Feb-2023 | NA | NA | In Analysis: Change rS = sum of all the peaks except those each of which with an area less than 0.1 times the area of the major peak from the Reference solution to: rT = sum of all the peaks except those… Read More |
ATORVASTATIN CALCIUM TABLETS | IMPURITIES/Organic Impurities | USPNF Online | Online | 30-Jun-2023 | 1-Jul-2023 | NA | NA | In Analysis: Change Mr1 = molecular weight of atorvastatin, 558.64 Mr2 = molecular weight of atorvastatin calcium, 1155.34 to: Mr1 = molecular weight of atorvastatin, 558.65 M… Read More |
<81> ANTIBIOTICS—MICROBIAL ASSAYS | APPENDICES | USPNF Online | Online | 29-Dec-2023 | 1-Jan-2024 | NA | NA | In two instances in Appendix 1 equations: Change 14.020 to: 14.022 |
AZITHROMYCIN FOR INJECTION | ADDITIONAL REQUIREMENTS | USPNF Online | Online | 28-Jul-2023 | 1-Aug-2023 | NA | USPNF 2024 Issue 2 | In USP Reference Standards 〈11〉/USP Azaerythromycin A RS: Change 734.96 to: 734.97 AND In USP Azithromycin N-oxide RS: Change 764.98 to: 765.00 AND In USP N-Demethylazithromycin RS: Change 734.96 to: 734.97… Read More |
IODIXANOL INJECTION | IMPURITIES | USPNF Online | Online | 23-Feb-2024 | 1-Mar-2024 | NA | NA | In Organic Impurities, Procedure 2/footnote 4: Change 5-[[3-[[3-[[[3-[[3-[[3,5-Bis-[[[2,3-dihydroxypropyl]amino]carbonyl]-2,4,6-triiodophenyl](acetylimino)]-2-hydroxypropyl](acetylimino)]-5-[[[2,3-dihydroxypropyl]amino]carbonyl]-2,4,6-triiodophenyl]carbonyl]amino]-2-hy… Read More |
HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE TABLETS | ASSAY/Procedure | USPNF Online | Online | 24-Jun-2022 | 1-Jul-2022 | NA | NA | In Buffer: Change Adjust with phosphoric acid to a pH of 6.4 ± 0.01. to: Adjust with phosphoric acid to a pH of 6.4 ± 0.1. |
MOMETASONE FUROATE TOPICAL SOLUTION | IDENTIFICATION | USPNF Online | Online | 18-Nov-2022 | 1-Dec-2022 | NA | NA | In test A: Change The retention time of the major peak of the Sample solution corresponds to that of the Standard solution, both relative to the internal standard, as obtained in the Assay. to: The retention time of the major… Read More |
VIGABATRIN TABLETS | IMPURITIES/Organic Impurities | USPNF Online | Online | 28-Apr-2023 | 1-May-2023 | NA | NA | In Analysis: Change CS = concentration of USP Vigabatrin Related Compound A in the Standard solution to: CS = concentration of USP Vigabatrin Related Compound A RS in the Standard solution |
AMOXICILLIN FOR INJECTABLE SUSPENSION | Identification | USPNF Online | Online | 27-Oct-2023 | 1-Nov-2023 | NA | NA | Change Prepare a test solution containing the equivalent of 4 mg of amoxicillin per mL by adding 0.1 N hydrochloric acid to Amoxicillin for Injectable Suspension. Allow the solution to stand for 5 minutes before use: the solution responds to the Identification… Read More |
SODIUM PICOSULFATE | IMPURITIES/Organic Impurities | USPNF Online | Online | 30-Sep-2022 | 1-Oct-2022 | NA | NA | In Buffer: Change cetylrimethylammonium bromide, to: cetyltrimethylammonium bromide, |
MIRTAZAPINE TABLETS | IMPURITIES/Organic Impurities | USPNF Online | Online | 24-Feb-2023 | 1-Mar-2023 | NA | NA | In System suitability/Suitability requirements/Resolution: Change 10-ketomirtazpine to: 10-ketomirtazapine AND In Table 1: Change 1-Ketomirtazpinec to: 1-Ketomirtazapinec |
DIMENHYDRINATE TABLETS | OTHER COMPONENTS/8-Chlorotheophylline | USPNF Online | Online | 27-May-2022 | 1-Jun-2022 | NA | NA | In Analysis: Change CU = nominal concentration of dimenhydrinate in the Sample solution (mg/mL) to: CU = determined concentration of dimenhydrinate in the Sample solution, as obtained in the Assay… Read More |
TETRACYCLINE HYDROCHLORIDE | ADDITIONAL REQUIREMENTS/Labeling | USPNF Online | Online | 28-Oct-2022 | 1-Nov-2022 | NA | NA | Change Where tetracycline hydrochloride must be sterile or subjected to further processing during the preparation of injectable dosage forms to ensure acceptable levels of bacterial endotoxins, it is so labeled. to: Where Tetracycline Hydrochloride must be… Read More |
PRAZOSIN HYDROCHLORIDE CAPSULES | ASSAY/Procedure | USPNF Online | Online | 31-Mar-2023 | 1-Apr-2023 | NA | NA | In Analysis: Change CS = concentration of USP Prazosin Hydrochloride RS in the Standard solution (µg/mL) CU = nominal concentration of prazosin in the Sample solution (µg/mL) Mr1… Read More |
CRANBERRY FRUIT DRY JUICE | COMPOSITION | USPNF Online | Online | 25-Aug-2023 | 1-Sep-2023 | NA | NA | In Content of Proanthocyanidins/Standard stock solution: Change USP Procyanidin A2 RS to: USP Procyanidin A2 RS AND In Content of Proanthocyanidins/Analysis: Change Use the absorbance recorded for Standard… Read More |
ENSULIZOLE | IDENTIFICATION | USPNF Online | Online | 29-Mar-2024 | 1-Apr-2024 | NA | NA | In B.: Change The retention time of the major peak of the Sample solution exhibits maxima and minima at the same wavelengths as those of the Standard solution, as obtained in the Assay. to: The retention time of the major… Read More |
BACLOFEN INJECTION | SPECIFIC TESTS | USPNF Online | Online | 29-Jul-2022 | 1-Aug-2022 | NA | NA | Change • Osmolality and Osmolarity 〈785〉, Osmolality: 270–320 mOsm/kg to: • Osmolality and Osmolarity 〈785〉 Osmolality: 270–320 mOsm/kg |
MESO-ZEAXANTHIN | CHEMICAL INFORMATION | USPNF Online | Online | 27-Jan-2023 | 1-Jun-2023 | NA | NA | Change (3R,3′S-meso)-Zeaxanthin to: (3R,3′S)-Zeaxanthin |
DIGOXIN TABLETS | ASSAY/Procedure | USPNF Online | Online | 30-Jun-2023 | 1-Jul-2023 | NA | NA | In Chromatographic system: Change Column: 4.2-mm × 25-cm; 5-μm packing L1 to: Column: 4.6-mm × 25-cm; 5-µm packing L1 |
DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE CAPSULES | ADDITIONAL REQUIREMENTS | USPNF Online | Online | 17-Nov-2023 | 1-Dec-2023 | NA | NA | In USP Reference Standards 〈11〉/USP Dihydrodutasteride RS: Change N-[2,5-Bis(trifluoromethyl)phenyl]-3-oxo-4-aza-5α-androst-1-ene-17β-carboxamide. to: N-[2,5-Bis(trifluoromethyl)phenyl]-3-oxo-4-aza-5α-androstane-17β-carboxamide. |
IVERMECTIN | CHEMICAL INFORMATION | USPNF Online | Online | 24-Jun-2022 | 1-Jul-2022 | NA | NA | Change C48H74O14(Component H2B1a) 875.09 C47H72O14(Component H2B1b) 861.07 Component H2B1a: Avermectin… Read More |
CALCIUM UNDECYLENATE | ASSAY/Procedure | USPNF Online | Online | 28-Oct-2022 | 1-Nov-2022 | NA | NA | In Solution A: Change 0.15 N hydrochloric acid in water prepared as follows. Transfer 150 mL of hydrochloric acid to a 500-mL volumetric flask, dilute with water to volume, and mix well. to: 0.15 N hydrochloric acid in water prepared as follows.… Read More |
ACARBOSE TABLETS | IDENTIFICATION/B. | USPNF Online | Online | 28-Apr-2023 | 1-May-2023 | NA | NA | Change The spectrum obtained from the Sample solution shows IR maxima in the regions of 3500–3200, 2950–2890, 1653–1633, and 1070–1000 cm–1. to: The spectrum obtained from the sample preparation shows IR maxima in the regions of 3500–3200… Read More |
VALGANCICLOVIR HYDROCHLORIDE | IMPURITIES | USPNF Online | Online | 25-Aug-2023 | 1-Sep-2023 | NA | NA | In Organic Impurities/Table 3/footnote c: Change 2-[(2-Amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]-2-hydroxypropyl methyl-L-valinate hydrochloride. to: 3-[(2-Amino-6-oxo-1,6-dihydropurin-9-yl)methoxy]-2-hydroxypropyl L… Read More |
POTASSIUM GLUCONATE | IMPURITIES/Reducing Substances | USPNF Online | Online | 26-Aug-2022 | 1-Sep-2022 | NA | NA | In Titrimetric system: Change Titrant: Iodine Back-titrant: Sodium thiosulfate to: Titrant: 0.1 N Iodine VS Back-titrant: 0.1 N Sodium Thiosulfate VS |
POLYETHYLENE GLYCOL STANDARDS WITH MOLECULAR WEIGHTS OF 1000, 2000, 3000, 4000, AND 6000 DALTONS (G/MOL) | CHEMICAL INFORMATION | USPNF Online | Online | 27-Jan-2023 | 1-Feb-2023 | NA | NA | Change CAS RN®: 25332-68-3. to: CAS RN®: 25322-68-3. |
<3> TOPICAL AND TRANSDERMAL DRUG PRODUCTS—PRODUCT QUALITY TESTS | SPECIFIC TESTS FOR TDS | USPNF Online | Online | 28-Jul-2023 | 1-Dec-2023 | NA | NA | In Release Liner Peel Test: Change The product fails the test if the mean peel force is outside the acceptable range determined during product development. to: The product fails the test if the overall mean peel force is outside the acceptable range… Read More |
ACARBOSE | IMPURITIES | USPNF Online | Online | 29-Dec-2023 | 1-Jan-2024 | NA | NA | In Chromatographic Purity/Analysis: Change Result = (rU/rA) × (1/F) × 100 to: Result = (rU/rA) × (1/F) |
REAGENTS AND REFERENCE TABLES | Solutions/Test Solutions and Indicator Solutions/Starch TS | USPNF Online | Online | 25-Aug-2023 | 1-Sep-2023 | NA | NA | Change Prepare this solution by one of the following procedures: to: Prepare this solution by one of the following procedures. Apply the Test for sensitivity to confirm suitability for freshly or previously prepared solutions or commercially bought… Read More |
IODIXANOL INJECTION | ADDITIONAL REQUIREMENTS | USPNF Online | Online | 23-Feb-2024 | 1-Mar-2024 | NA | NA | In USP Reference Standards 〈11〉/USP Iodixanol Related Compound E RS: Change 5-[[3-[[3-[[(2,3-Dihydroxypropyl)amino]carbonyl]-5- [[amino]carbonyl]-2,4,6-triiodophenyl](acetylimino)]-2-hydroxypropyl]-(acetylimino)]-N,N′-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-… Read More |
HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE TABLETS | IMPURITIES/Limit of Homatropine Hydrobromide and Related Substances | USPNF Online | Online | 24-Jun-2022 | 1-Jul-2022 | NA | NA | In Buffer: Change Adjust with phosphoric acid to a pH of 6.4 ± 0.01. to: Adjust with phosphoric acid to a pH of 6.4 ± 0.1. |
ROCURONIUM BROMIDE | CHEMICAL INFORMATION | USPNF Online | Online | 18-Nov-2022 | 1-Dec-2022 | NA | USPNF 2023 Issue 3 | Change 609.68 to: 609.69 |
FLUVOXAMINE MALEATE TABLETS | ASSAY/Procedure | USPNF Online | Online | 28-Apr-2023 | 1-May-2023 | NA | NA | In Solution A: Change 8 g/L of 1-pentanesulfonic acid sodium salt and 1 g/L of monobasic potassium phosphate in water. to: 8 g/L of 1-pentanesulfonic acid sodium salt and 1.1 g/L of monobasic potassium phosphate in water. |
TELMISARTAN TABLETS | ASSAY | USPNF Online | Online | 27-Oct-2023 | 1-Nov-2023 | NA | NA | In Procedure/System suitability/Suitability requirements: Change Resolution: NLT 3 between telmisartan and telmisartan related compound A Tailing factor: NMT 2.0 for the telmisartan peak Capacity factor: NLT… Read More |
TERAZOSIN CAPSULES | ASSAY/Procedure | USPNF Online | Online | 30-Sep-2022 | 1-Oct-2022 | NA | NA | In Hydrochloric acid solution: Change 0.1 N methanolic hydrochloric acid to: 0.01 N methanolic hydrochloric acid |
LIDOCAINE HYDROCHLORIDE AND DEXTROSE INJECTION | Assay for lidocaine hydrochloride | USPNF Online | Online | 24-Feb-2023 | 1-Mar-2023 | NA | NA | Change Proceed with Injection as directed in the Assay for lidocaine hydrochloride under Lidocaine and Epinephrine Injection. to: Proceed with Injection as directed in the Assay for lidocaine hydrochloride under Lidocaine… Read More |
RIFABUTIN | CHEMICAL INFORMATION | USPNF Online | Online | 27-May-2022 | 1-Jun-2022 | NA | NA | Change 847.00 to: 847.02 AND Change (9S,12E,14S,15R,16S,17R,18R,19R,20S,21S,22E,24Z)-6,16,18,20-Tetrahydroxy-1′-isobutyl-14-methoxy-7,9,15,17,19,21,25-heptamethylspiro[9,4-(epoxypentadeca[1,11,13]… Read More |
SITAGLIPTIN PHOSPHATE | CHEMICAL INFORMATION | USPNF Online | Online | 28-Oct-2022 | 1-Nov-2022 | NA | NA | Change 523.32 to: 523.33 AND Change (3R)-3-Amino-1-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl-4-(2,4,5-trifluorophenyl)butan-1-one phosphate monohydrate to: (3R)-3-Amino-1-[3-(trifluoromethyl)-… Read More |
PRAZOSIN HYDROCHLORIDE CAPSULES | PERFORMANCE TESTS/Dissolution 〈711〉 | USPNF Online | Online | 31-Mar-2023 | 1-Apr-2023 | NA | NA | In Test 2/Analysis: Change CS = concentration of USP Prazosin Hydrochloride RS in the Standard solution (µg/mL) to: CS = concentration of USP Prazosin Hydrochloride RS in the Standard… Read More |
CRANBERRY FRUIT DRY JUICE | ADDITIONAL REQUIREMENTS | USPNF Online | Online | 25-Aug-2023 | 1-Sep-2023 | NA | NA | In USP Reference Standards 〈11〉: Change USP Procyanidin A2 RS to: USP Procyanidin A2 RS |
RIVASTIGMINE TARTRATE | IMPURITIES | USPNF Online | Online | 26-Apr-2024 | 1-May-2024 | NA | NA | In Organic Impurities/Procedure 1/Impurity Table 1/footnote d: Change 3-Nitrophenyl ethyl(methyl)carbamate. to: 4-Nitrophenyl ethyl(methyl)carbamate. |
MELOXICAM ORAL SUSPENSION | PERFORMANCE TESTS/Dissolution <711> | USPNF Online | Online | 29-Jul-2022 | 1-Aug-2022 | NA | NA | In Analysis: Change WU = weight of the Oral Suspension taken (mg) to: WU = weight of the Oral Suspension taken (g) |
MESO-ZEAXANTHIN | IDENTIFICATION/C. | USPNF Online | Online | 27-Jan-2023 | 1-Jun-2023 | NA | NA | Change (3R,3′S-meso)-zeaxanthin to: (3R,3′S)-zeaxanthin |
SITAGLIPTIN PHOSPHATE | IMPURITIES/Organic Impurities | USPNF Online | Online | 30-Jun-2023 | 1-Jul-2023 | NA | NA | In Analysis: Change CS = concentration of USP Sitagliptin Phosphate in the Standard solution (mg/mL) to: CS = concentration of USP Sitagliptin Phosphate RS in the Standard solution (mg/mL) |
NORFLURANE | IMPURITIES | USPNF Online | Online | 17-Nov-2023 | 1-Dec-2023 | NA | NA | In Organic Impurities/Table 2: Change Line No. to: Peak Elution Order AND In Halides/Figure 1: Add label Flow Meter |
DOXYCYCLINE CAPSULES | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF Online | Online | 24-Jun-2022 | 1-Jul-2022 | NA | NA | In USP Doxycycline Related Compound A RS: Change 444.43 to: 444.44 AND Change (4S,4aR,5S,5aR,6S,12aS)-4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide… Read More |
ANETHOLE | DEFINITION | USPNF Online | Online | 28-Oct-2022 | 1-Nov-2022 | NA | NA | Change (E)-1-methyl-4-(1-propenyl) benzene to: (E)-1-methoxy-4-(1-propenyl) benzene |
BISOPROLOL FUMARATE | CHEMICAL INFORMATION | USPNF Online | Online | 28-Apr-2023 | 1-May-2023 | NA | NA | Change (±)-1-[[α-(2-Isoproproxyethoxy)-p-tolyl]oxy]-3-(isopropyl amino)-2-propanol fumarate (2:1) (salt) to: (±)-1-[[α-(2-Isoproproxyethoxy)-p-tolyl]oxy]-3-(isopropylamino)-2-propanol fumarate (2:1) (salt) |
DIGOXIN TABLETS | ASSAY | USPNF Online | Online | 29-Sep-2023 | 1-Oct-2023 | NA | NA | In Procedure/Analysis: Change CU = nominal concentration of in the Sample solution (µg/mL) to: CU = nominal concentration of digoxin in the Sample solution (µg/mL) |